These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. The role of Ca2+ in regulating the catabolism of PAF-acether (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) in rabbit platelets. Touqui L; Shaw AM; Dumarey C; Jacquemin C; Vargaftig BB Biochem J; 1987 Jan; 241(2):555-60. PubMed ID: 3109377 [TBL] [Abstract][Full Text] [Related]
27. Activation of guinea pig eosinophils by human recombinant IL-5. Selective priming to platelet-activating factor-acether and interference of its antagonists. Coëffier E; Joseph D; Vargaftig BB J Immunol; 1991 Oct; 147(8):2595-602. PubMed ID: 1655895 [TBL] [Abstract][Full Text] [Related]
28. Continuous binding of the PAF molecule to its receptor is necessary for the long-term aggregation of platelets. Suzuki M; Sugatani J; Ino M; Shimura M; Akiyama M; Yamazaki R; Suzuki Y; Miwa M Am J Physiol; 1998 Jan; 274(1):C47-57. PubMed ID: 9458712 [TBL] [Abstract][Full Text] [Related]
29. 1-O-hexadecyl-2-acetyl-sn-glycero-3-phospho (N,N,N trimethyl) hexanolamine: an analogue of platelet-activating factor with partial agonist activity. Grigoriadis G; Stewart AG Br J Pharmacol; 1991 Sep; 104(1):171-7. PubMed ID: 1664761 [TBL] [Abstract][Full Text] [Related]
30. A Penicillium sp. F33 metabolite and its synthetic derivatives inhibit acetyl-CoA:1-O-alkyl-sn-glycero-3-phosphocholine acetyltransferase (a key enzyme in platelet-activating factor biosynthesis) and carrageenan-induced paw edema in mice. Yamazaki Y; Yasuda K; Matsuyama T; Ishihara T; Higa R; Sawairi T; Yamaguchi M; Egi M; Akai S; Miyase T; Ikari A; Miwa M; Sugatani J Biochem Pharmacol; 2013 Sep; 86(5):632-44. PubMed ID: 23817078 [TBL] [Abstract][Full Text] [Related]
31. Species-dependent differences of high affinity [3H]PAF-binding to platelets from humans and pigs and its inhibition by selected antagonists. Ostermann G; Lorenz A; Hofmann B; Kertscher HP J Lipid Mediat; 1991 Nov; 4(3):289-98. PubMed ID: 1662546 [TBL] [Abstract][Full Text] [Related]
32. LTB4, a potent chemotactic factor for purified guinea-pig eosinophils: interference of PAF-acether antagonists. Coëffier E; Joseph D; Vargaftig BB Int J Immunopharmacol; 1991; 13(2-3):273-80. PubMed ID: 1649143 [TBL] [Abstract][Full Text] [Related]
33. The enantiomer and the positional isomer of platelet-activating factor. Tence M; Coëffier E; Polonsky J; Benveniste J Biochim Biophys Acta; 1983 Feb; 755(3):526-30. PubMed ID: 6824744 [TBL] [Abstract][Full Text] [Related]
34. Binding kinetics of PAF-acether (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) to intact human platelets. Kloprogge E; Akkerman JW Biochem J; 1984 Nov; 223(3):901-9. PubMed ID: 6150705 [TBL] [Abstract][Full Text] [Related]
35. The platelet-independent release of thromboxane A2 by Paf-acether from guinea-pig lungs involves mechanisms distinct from those for leukotriene. Lefort J; Rotilio D; Vargaftig BB Br J Pharmacol; 1984 Jul; 82(3):565-75. PubMed ID: 6430375 [TBL] [Abstract][Full Text] [Related]
36. Biosynthesis of paf-acether: VIII: Impairment of paf-acether production in activated macrophages does not depend upon acetyltransferase activity. Roubin R; Dulioust A; Haye-Legrand I; Ninio E; Benveniste J J Immunol; 1986 Mar; 136(5):1796-802. PubMed ID: 3950403 [TBL] [Abstract][Full Text] [Related]
37. Relaxation of the guinea-pig trachea induced by platelet-activating factor and by serotonin. Prancan A; Lefort J; Barton M; Vargaftig BB Eur J Pharmacol; 1982 May; 80(1):29-35. PubMed ID: 7095003 [TBL] [Abstract][Full Text] [Related]
38. Activation of guinea pig peritoneal macrophages by platelet activating factor (PAF) and its agonists. Hayashi H; Kudo I; Inoue K; Onozaki K; Tsushima S; Nomura H; Nojima S J Biochem; 1985 Jun; 97(6):1737-45. PubMed ID: 2993272 [TBL] [Abstract][Full Text] [Related]
39. Effect of Y-24180, a long-acting antagonist to platelet-activating factor (PAF), on PAF-induced reactions: a relationship between the partial structure of the compound and its duration of the action. Kagoshima M; Tomomatsu N; Iwahisa Y; Yamaguchi S; Kawakami Y; Terasawa M Pharmacology; 1997 May; 54(5):261-70. PubMed ID: 9380772 [TBL] [Abstract][Full Text] [Related]